On January 5, 2025, the Pasteur Institute of Iran and the Razi Vaccine and Serum Research Institute held a high-level strategic meeting at the Razi Institute’s headquarters. The session aimed to create a detailed roadmap for enhanced collaboration, focusing on consolidating Iran's scientific and public health capabilities through a unified national effort. Central to the discussions was the imperative to integrate the distinct strengths and resources of both venerable institutions. Leaders unanimously agreed that synergy in vaccine development and biological product innovation is crucial for addressing national health priorities and bolstering health security. The dialogue emphasized that pooling expertise and infrastructure would prevent duplication of effort, optimize financial resources, and accelerate the output of essential biomedical products.

During the meeting. Dr. Ehsan Mostafavi, the Director General of the Pasteur Institute of Iran outlined key collaborative domains, including joint manufacturing, shared immunology and virology research platforms, specialist training, and technology transfer. He stressed the need for harmonized policy-making in vaccine R&D and diagnostics. Dr. Ali Es-haghi, the President of the Razi Institute echoed this, advocating for all future scientific programs and public engagements to project a single, cohesive identity. As a flagship initiative, they announced the co-organization of The first International Congress on Vaccines and Vaccination in April 2026. The meeting also covered operational plans for exchanging technical knowledge, sharing laboratory facilities, and establishing a joint strategic planning committee. The session concluded with a tour of the Razi Vaccine and Serum Research Institute departments.